Stay updated on PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial

Sign up to get notified when there's something new on the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.5%
    Check dated 2025-03-03T22:50:42.000Z thumbnail image
  3. Check
    26 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.5%
    Check dated 2025-02-10T15:42:46.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.0%
    Check dated 2025-02-03T10:54:29.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.0%
    Check dated 2025-01-20T01:57:28.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The website has updated the intervention details to include a verified status from June 2021, indicating it is currently active but not recruiting, while also reflecting a revision change from v2.13.3 to v2.14.0.
    Difference
    0.3%
    Check dated 2025-01-12T22:40:52.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.0%
    Check dated 2024-12-14T23:18:31.000Z thumbnail image

Stay in the know with updates to PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page.